Literature DB >> 21908172

Prevalence of cataract surgery and postoperative visual outcome in rural central India Central India Eye and Medical Study.

Vinay Nangia1, Jost B Jonas, Rajesh Gupta, Anshu Khare, Ajit Sinha.   

Abstract

PURPOSE: To determine the prevalence of cataract surgery and the postoperative visual outcomes in rural central India.
SETTING: Villages in rural central India.
DESIGN: Cohort study.
METHODS: The population-based Central India Eye and Medical Study examined the prevalence of surgical pseudophakia/aphakia, the postoperative visual acuity, and the reasons for decreased postoperative vision in subjects aged 30+ in rural central India. Visual impairment was defined as (1) presenting visual acuity worse than 6/18 or (2) corrected distance visual acuity (CDVA) worse than 6/18.
RESULTS: Of the 9392 eyes (99.7%) of 4711 subjects with available data on the lens status, 318 eyes (3.4%) (234 patients, 129 women) had had cataract surgery (5.0% ± 0.3%). Cataract surgery was significantly associated with age (P<.001), female sex (P = .008), shorter axial length (P<.001), and diabetes mellitus (P<.001). The prevalence of postoperative presenting visual impairment was 63% (201/318 eyes) and of postoperative CDVA impairment, 36% (117/318 eyes). The major cause of the former was incorrect intraocular lens (IOL) power (42%); the major causes of the latter were posterior capsule opacification (24%), surgical complications (21%), age-related macular degeneration (10.3%), other macular disorders (4.3%), corneal opacities (3.4%), and glaucoma (2.0%). Surgical complications were significantly more common in the aphakic group than in the pseudophakic group (46.4% versus 2.0%; P<.001).
CONCLUSIONS: Approximately 5% of the central India population aged 30 years or older had had cataract surgery. Postoperative visual impairment was present in 2 of 3 eyes. The major reasons were incorrect IOL power and surgical complications. Improved IOL power calculations and improved surgical techniques may markedly improve postoperative outcome. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2011 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21908172     DOI: 10.1016/j.jcrs.2011.08.020

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  5 in total

1.  Uptake, Barriers and Outcomes in the Follow-up of Patients Referred for Free-of-Cost Cataract Surgery in the Sao Paulo Eye Study.

Authors:  Marcia H Mitsuhiro; Adriana Berezovsky; Rubens Belfort; Leon B Ellwein; Solange R Salomao
Journal:  Ophthalmic Epidemiol       Date:  2014-10-13       Impact factor: 1.648

2.  Prevalence of cataract surgery and visual outcomes in Indian immigrants in Singapore: the Singapore Indian eye study.

Authors:  Preeti Gupta; Yingfeng Zheng; Tay Wan Ting; Ecosse L Lamoureux; Ching-Yu Cheng; Tien-Yin Wong
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

3.  The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland.

Authors:  Michal Szymon Nowak; Janusz Smigielski
Journal:  J Ophthalmol       Date:  2015-02-19       Impact factor: 1.909

4.  The impact of pseudophakia on vision-related quality of life in the general population - The Gutenberg Health Study.

Authors:  Alexander K Schuster; Norbert Pfeiffer; Andreas Schulz; Stefan Nickels; René Höhn; Philipp S Wild; Maria Blettner; Thomas Münzel; Manfred E Beutel; Karl J Lackner; Urs Vossmerbaeumer
Journal:  Aging (Albany NY)       Date:  2017-03-28       Impact factor: 5.682

5.  Prevalence and associated factors of cataract and cataract-related blindness in the Russian Ural Eye and Medical Study.

Authors:  Mukharram M Bikbov; Gyulli M Kazakbaeva; Timur R Gilmanshin; Rinat M Zainullin; Ildar F Nuriev; Artur F Zaynetdinov; Gulnara Z Israfilova; Songhomitra Panda-Jonas; Inga I Arslangareeva; Ellina M Rakhimova; Iulia A Rusakova; Jost B Jonas
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.